IMMX
Immix Biopharma Inc
9.70$
-5.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +122.7% | +675.4% | +1.9% | +6.6% | +59.6% | +43.2% | +34.9% | +68.9% | -32.8% | +44.3% | +0.1% | – | |
| – | +42.5% | -10.2% | -32.4% | +15.0% | -3.8% | +23.1% | -38.7% | -11.6% | +21.3% | +0.8% | +69.9% | – | |
| – | – | -62.3% | -381.6% | – | +10.0% | -25.5% | -63.7% | +53.4% | -193.4% | – | – | – | |
| – | -66.1% | +2,191.2% | -67.8% | +179.7% | +86.8% | -86.6% | +88.5% | +191.8% | -55.7% | -80.3% | -35.2% | – | |
| – | -66.1% | +2,191.2% | -67.8% | +179.7% | +86.8% | -86.6% | +88.5% | +191.8% | +1,684.4% | -27.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -94.2% | +2,618.4% | +0.0% | -100.0% | – | – | – | +855.6% | +801.8% | -100.0% | – | – | |
| – | -129.9% | – | -145.3% | – | – | – | – | – | +1,709.6% | -118.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.